Ethics in Behavioral Healthcare Business Operations​

Chicago, IL - Wednesday, August 2, 2017 at 11am-1pm (CT)
Behavioral healthcare is a rapidly growing field. As more funding has become available, many new programs have opened, existing centers have expanded, and access to care has increased. Concurrent with this growth, however, have been ethical concerns as programs rapidly transform.
Owners and operators are concerned about competing with organizations that engage in patient brokering, misrepresentation in marketing, overreliance on drug testing, and inaccurate or fraudulent financial and outcomes data. Reputable providers face ethical dilemmas as they balance growth and investment opportunities on one hand with providing effective and efficient patient care on the other. Join Behavioral Healthcare for a panel discussion exploring these topics.
Upon attending this program, attendees will be able to:
  • Understand basic dos and don'ts of ethical marketing
  • Identify the proper use of drug testing in an ethical treatment program
  • Identify financial best practices in treatment operations
  • Understand how technology can be used to provide accurate data 
One hour of continuing education credit will be available.

Maggiano's Little Italy
240 Oakbrook Center
Oak Brook, IL 60523


Dr. Kirk Taylor
Chief Medical Officer, Prescient
Currently serving as Chief Medical Officer, Dr. Kirk Taylor brings more than 20 years of experience in the pharmaceutical industry and 12 years in clinical practice to Prescient. He has lead cross-functional teams covering many parts of the world including the US, Europe, Latin America, Canada, Africa, and Asia. He has held executive leadership positions at Pfizer, Actelion, Biogen, Alzheon, and Sanofi Genzyme focusing on late stage clinical development and medical affairs. Past duties have included strategic life cycle management, payer engagement, launch planning, clinical operations, medical field team design and deployment, product label negotiations, NDA preparation and filing, medical communication plans, scientific training, and thought leader engagement. He was instrumental in many product launches including Relpax, Macugen, Lyrica, Tecfidera, Alprolix, and Eloctate. Past therapeutic areas include neurology, psychiatry, ophthalmology, hemophilia, rare diseases, and pulmonary arterial hypertension. He has managed multi-million dollar medical budgets throughout his career, including P&L responsibility. Dr. Taylor received his BA from Harvard University and his MD from SUNY Downstate. He completed his internship at Roosevelt Hospital Columbia University, his neurology residency at the Albert Einstein College of Medicine and a postdoc in neuropathic pain and headache from UCSF. He was on faculty at UCSF in the neurology department before joining Pfizer, and saw patients for 12 years at the Urban Health Plan in the Bronx, New York. He also completed Executive MBA programs at Harvard Business School and INSEAD. Originally from the Bronx, New York, Dr. Taylor sits on the Massachusetts Board of Directors for Bottom Line, a non-profit organization that addresses the low college graduation rates of low-income and first-generation students.
Harry Nelson
Founder/Managing Partner, Nelson Hardiman
Harry Nelson is the founder and managing partner of Nelson Hardiman, a healthcare specialty firm which is annually ranked among the best “Health Care Law” firms by U.S. News & World Report. Harry has a solid track record of leadership developing practical solutions to many industry challenges with particular expertise in post-acute and behavioral health. He has written extensively about the national opioid epidemic and addiction treatment, speaks regularly at behavioral health conferences, and launched the American Addiction Treatment Association (AATA), serving on its board. AATA is a national trade association which prides itself on being the first organization to offer national legal, regulatory, and compliance resources in the area of addiction treatment, enabling recovery industry professionals, owners, and operators to navigate the evolving clinical and regulatory landscapes.
Proactively tackling timely healthcare issues, Harry is the co-author of the recently released book, “From Obamacare to Trumpcare: Why You Should Care.” This new book offers a comprehensive survey of healthcare policy leading up to the Affordable Care Act, examines its strengths and weaknesses, and portends the direction the Trump administration and the GOP will take on healthcare policy. It provides an unbiased assessment of the potential impact this historical policy transition will have on patients and practitioners. Harry’s thought leadership around the future of the healthcare and life sciences industry has also driven many next-generation healthcare ideas and initiatives to realization, including in telehealth and other modalities of digital health and behavioral health.
*There is a $25 registration fee, but all attendees will receive a $25 American Express gift card at the conclusion of the event.
Registration is required to attend; seating is limited.